PRODUCT SPECIFICATION Strength / Dose: 400 mg Dosage Form: Concentrate for intravenous infusion Packing Type: Glass vial with rubber stopper, packed in carton Treatment:
Used in the treatment of:
Metastatic colorectal cancer
Renal cell carcinoma
Glioblastoma
NSCLC and ovarian cancers
Bevacizumab is a VEGF-inhibiting monoclonal antibody that prevents angiogenesis and restricts tumor blood supply.
Prescription Type: Prescription only (Rx) Generic Name (Drug Name): Bevacizumab Brand: Bevakalp 400
PRODUCT SPECIFICATION
Strength / Dose: 200 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) in appropriate patient populations (as per local/regional approval)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Azacitidine
Brand: Azatend-O
PRODUCT SPECIFICATION
Strength / Dose: 50 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of various malignancies (e.g., lymphomas, leukaemias, solid tumours) and sometimes in non-oncology immunosuppressive settings (as per approved uses)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Cyclophosphamide
Brand: Cycloxan
PRODUCT SPECIFICATION
Strength / Dose: 25 mg per capsule
Dosage Form: Oral capsule
Packing Type: Capsules in blister or bottle, packed in carton
Treatment: Used in the treatment of certain haematologic malignancies (e.g., multiple myeloma) according to approved indication
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Lenalidomide
Brand: Laviat 25